Literature DB >> 16314827

Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro.

Agnieszka Bonar1, Magdalena Chmiela, Wiesława Rudnicka, Barbara Rózalska.   

Abstract

INTRODUCTION: Phagocytosis is the critical first step in the Mycobacterium (M.) tuberculosis-phagocyte interaction. The process involves microbial ligands and phagocyte surface receptors. It is known that serum mannose-binding lectin (MBL), an innate immune system component, may enhance the uptake of microbes by phagocytic cells and activate the complement system. Since phagocytes are the replicative environment for mycobacteria and, as we described earlier, tuberculosis patients differ from controls in serum MBL level, we asked whether MBL plays a role in promoting M. tuberculosis access to phagocytic cells. MATERIAL/
METHODS: To estimate the influence of MBL on the phagocytic process, FITC-labeled Mycobacterium bovis BCG was used as a model bacterium. Neutrophils from healthy individuals were used as phagocytes. Phagocytosis was performed in the presence or absence of recombinant MBL (rMBL; 2 or 20 microg/ml). The activation of complement was determined by dot-blot immune assay with monoclonal antibodies against C5b-C9.
RESULTS: We showed that phagocytosis of the bacteria was more intensive in the presence of human rMBL. Both attachment and ingestion of mycobacteria were enhanced when MBL and active complement components (fresh serum) were present in the medium. The dot-blot method showed that the bacteria slightly activated complement by themselves. This effect was enhanced in the phagocyte-bacteria co-cultures containing rMBL.
CONCLUSIONS: It is possible that MBL may serve in vivo as one of the factors facilitating the entry of mycobacteria into phagocytes, pathogen spread, and the establishment of infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314827

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  8 in total

Review 1.  Mannan-binding lectin in asthma and allergy.

Authors:  Savneet Kaur; Steffen Thiel; P Usha Sarma; Taruna Madan
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.

Authors:  M A Bartlomiejczyk; A S Swierzko; A Brzostek; J Dziadek; M Cedzynski
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

3.  Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.

Authors:  L N Dornelles; L Pereira-Ferrari; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

4.  Bridging effect of recombinant human mannose-binding lectin in macrophage phagocytosis of Escherichia coli.

Authors:  Akiko Shiratsuchi; Ikuko Watanabe; Jin-Sung Ju; Bok Luel Lee; Yoshinobu Nakanishi
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

5.  Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.

Authors:  Stefan Müller; Thomas Schaffer; Alain M Schoepfer; Annamarie Hilty; Thomas Bodmer; Frank Seibold
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

6.  Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Magdalena Klink; Marta Brzezinska; Izabela Szulc; Anna Brzostek; Michal Kielbik; Zofia Sulowska; Jaroslaw Dziadek
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 7.  Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.

Authors:  Leopold D Tientcheu; Anastasia Koch; Mthawelenga Ndengane; Genevieve Andoseh; Beate Kampmann; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2017-02-24       Impact factor: 5.532

8.  Association of MBL2 Exon 1 Polymorphisms With Multibacillary Leprosy.

Authors:  Bruna Tiaki Tiyo; Evelyn Castillo Lima Vendramini; Victor Hugo de Souza; Cristiane Maria Colli; Hugo Vicentin Alves; Ana Maria Sell; Sylmara Bessani Paixão Zucoloto; Jeane Eliete Laguila Visentainer
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.